S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7124 +0.21%
PRE-MKT · 08:30 ET
Market ClerkRecap
Thu Oct 22 · pre-market6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead
DA
INSIDER · MAZE · Maze Therapeutics, Inc. · CSBO

Dandekar Atul

Every open-market transaction filed under this name, Aug 28 to Sep 29.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$578K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 29MAZEMaze Therapeutics, Inc.CSBOSell7,500$27.06$203K—
Sep 3MAZEMaze Therapeutics, Inc.CSBOSell3,207$26.01$83K—
Sep 2MAZEMaze Therapeutics, Inc.CSBOSell391$27.12$11K—
Sep 2MAZEMaze Therapeutics, Inc.CSBOSell2,800$26.38$74K—
Aug 28MAZEMaze Therapeutics, Inc.CSBOSell7,500$27.58$207K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.